However, the KRAS(G12C) only covers a small proportion of KRAS mutations, which were found in ~13% of lung adenocarcinomas, 3% of colorectal cancer, and at a lower frequency in other cancers (less than 1% in pancreatic cancer)2,4,6. This evidence concerns the gene KRAS and lung adenocarcinoma.